Literature DB >> 15981478

Peripheral generation and function of CD4+CD25+ regulatory T cells.

L S Taams1, A N Akbar.   

Abstract

The balance between immunity and tolerance is important to maintain immune homeostasis. Several mechanisms are in place to ensure that the immune response is controlled, such as T cell anergy, apoptosis and immune ignorance. A fourth mechanism of peripheral tolerance is the active suppression by regulatory or suppressor T cells. The existence of suppressor T cells was first described in the early 1970s, but these cells became discredited in the 1980s. The work of Shimon Sakaguchi and others, however, has brought these cells back into the limelight and nowadays research into regulatory/suppressor T cells is a very active field of immunology. Different types of regulatory T cells have been described, including CD4+CD25+ T cells that constitutively express CTLA-4, GITR and Foxp3, TGF-beta producing Th3 cells, IL-10 producing Tr1 cells, and CD8+CD28- T cells. This review will focus on the generation and function of CD4+CD25+ regulatory T cells. CD4+CD25+ regulatory cells were originally described as thymus-derived anergic/suppressive T cells. Recent papers, however, indicate that these cells might also be generated in the periphery. CD4+CD25+ regulatory T cells can be activated by self-antigens and non-self-antigens, and once activated can suppress T cells in an antigen nonspecific manner. Interestingly, the suppressive effects of these cells are not restricted to the adaptive immune system (T and B cells) but can also affect the activation and function of innate immune cells (monocytes, macrophages, dendritic cells). These features make the CD4+CD25+ regulatory T cell subset an interesting target for immunotherapy of chronic inflammatory or autoimmune diseases.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15981478     DOI: 10.1007/3-540-27702-1_6

Source DB:  PubMed          Journal:  Curr Top Microbiol Immunol        ISSN: 0070-217X            Impact factor:   4.291


  22 in total

1.  Aqueous extract of Caesalpinia sappan decelerates allograft rejection by inducing imbalance between CD4(+) CD25(+) T cells and Th17 cells.

Authors:  Chunxia Li; Hui Zhang; Dongqin Gao; Qun Ma; Zhihua Li; Jun Dai; Mingyan Zhang; Chuanping Si
Journal:  Int J Clin Exp Med       Date:  2015-05-15

2.  Inhibition of autoimmune type 1 diabetes by gastrointestinal helminth infection.

Authors:  Karin A Saunders; Tim Raine; Anne Cooke; Catherine E Lawrence
Journal:  Infect Immun       Date:  2006-10-16       Impact factor: 3.441

3.  B cell mediated priming following pneumococcal colonization.

Authors:  Bradley Rabquer; Anne K Shriner; S Louise Smithson; M A Julie Westerink
Journal:  Vaccine       Date:  2006-11-28       Impact factor: 3.641

Review 4.  SHP-1 and SHP-2 in T cells: two phosphatases functioning at many levels.

Authors:  Ulrike Lorenz
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

5.  CD8+CD28- cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients.

Authors:  Bülent Karagöz; Oğuz Bilgi; Mahmut Gümüs; Alev Akyol Erikçi; Ozkan Sayan; Orhan Türken; Emin Gökhan Kandemir; Ahmet Oztürk; Mustafa Yaylaci
Journal:  Med Oncol       Date:  2009-01-16       Impact factor: 3.064

6.  Functional islet-specific Treg can be generated from CD4+CD25- T cells of healthy and type 1 diabetic subjects.

Authors:  S Alice Long; Mindi R Walker; Mary Rieck; Eddie James; William W Kwok; Srinath Sanda; Catherine Pihoker; Carla Greenbaum; Gerald T Nepom; Jane H Buckner
Journal:  Eur J Immunol       Date:  2009-02       Impact factor: 5.532

7.  Foxp3 expression in p53-dependent DNA damage responses.

Authors:  Da-Jung Jung; Dong-Hoon Jin; Seung-Woo Hong; Jee-Eun Kim; Jae-Sik Shin; Daejin Kim; Byung-Joo Cho; Young-Il Hwang; Jae-Seung Kang; Wang-Jae Lee
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

8.  Daily subcutaneous injections of peptide induce CD4+ CD25+ T regulatory cells.

Authors:  P E Dahlberg; J M Schartner; A Timmel; C M Seroogy
Journal:  Clin Exp Immunol       Date:  2007-05-09       Impact factor: 4.330

9.  VASCULAR INFLAMMATION AND ATHEROGENESIS ARE ACTIVATED VIA RECEPTORS FOR PAMPs AND SUPPRESSED BY REGULATORY T CELLS.

Authors:  Xiao-Feng Yang; Ying Yin; Hong Wang
Journal:  Drug Discov Today Ther Strateg       Date:  2008

Review 10.  T cells with regulatory activity in hepatitis C virus infection: what we know and what we don't.

Authors:  Angela Dolganiuc; Gyongyi Szabo
Journal:  J Leukoc Biol       Date:  2008-05-21       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.